Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mensing

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1986
[Clinical aspects of progressive systemic scleroderma (PSS). Multicenter studies of 194 patients]G Goerz, G Hammer, G Wirth, et al.
The British Journal of Dermatology|February 19, 2009
Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studiesA Hauschild, E Stockfleth, G Popp, et al.
The British Journal of Dermatology|October 7, 2009
Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months dataR-M Szeimies, E Stockfleth, G Popp, et al.
The British Journal of Dermatology|December 29, 2015
The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodiesN Hunzelmann, G Riemekasten, M O Becker, et al.
The British Journal of Dermatology|September 14, 2011
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placeboT Dirschka, P Radny, R Dominicus, et al.
The British Journal of Dermatology|December 21, 2012
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosisT Dirschka, P Radny, R Dominicus, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1986
[Clinical aspects of progressive systemic scleroderma (PSS). Multicenter studies of 194 patients]G Goerz, G Hammer, G Wirth, et al.
The British Journal of Dermatology|February 19, 2009
Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studiesA Hauschild, E Stockfleth, G Popp, et al.
The British Journal of Dermatology|October 7, 2009
Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months dataR-M Szeimies, E Stockfleth, G Popp, et al.
The British Journal of Dermatology|December 29, 2015
The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodiesN Hunzelmann, G Riemekasten, M O Becker, et al.
The British Journal of Dermatology|September 14, 2011
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placeboT Dirschka, P Radny, R Dominicus, et al.
The British Journal of Dermatology|December 21, 2012
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosisT Dirschka, P Radny, R Dominicus, et al.
Pageof 12